EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

13-week dietary toxicity study of ammonium perfluorooctanoate (APFO) in male rats



13-week dietary toxicity study of ammonium perfluorooctanoate (APFO) in male rats



Drug and Chemical Toxicology 27(4): 361-378



Ammonium perfluorooctanoate is a perfluorinated carboxylate that is used commercially as a processing aid in the production of fluorinated polymers. Perfluorooctanoate (PFOA) has been found in human blood of the general population from exogenous sources. This report presents the results of a 13-week dietary toxicity study in male rats and was designed to identify potential target organ(s), dose response, and to explore possible relationships of PPARalpha activation to potential liver effects and hormonal changes. Rats were fed dietary levels of 0, 1, 10, 30, and 100 ppm (equivalent to 0, 0.06, 0.64, 1.94, and 6.5 mg/kg/day) for 13 weeks. A control group pair-fed adjusted to the 100 ppm level and groups allowed to recover for 8 weeks were included. Sacrifices were conducted after 4, 7, and 13 weeks of feeding and after 8 weeks of recovery. At each sacrifice, gross and histopathology was conducted on selected tissues and measurements of hepatic palmitoyl CoA oxidase (PCoAO), as well as serum estradiol, luteinizing hormone, testosterone, and PFOA were determined. There were no clinical signs or mortality. Body weight gains were reduced in the 100 ppm dose group. Liver weights (absolute and relative), PCoAO activity, and hepatocyte hypertrophy (minimal to mild) were increased in the 10 ppm dose group and above and were reversible in recovery. Under the study conditions, hormone levels appeared unchanged. PFOA serum concentrations increased in a dose-related fashion, appeared to reach steady-state by test week 5, and declined rapidly through the recovery period. Serum PFOA concentrations at the end of the treatment period were 7.1, 41, 70, and 138 microg/mL in the 1, 10, 30 and 100 ppm dose groups. The study no effect level was 1 ppm (0.06 microg/mg) with doses of 10 ppm (0.64 microg/mg) and higher producing adaptive and reversible liver changes.

(PDF emailed within 0-6 h: $19.90)

Accession: 004013453

Download citation: RISBibTeXText

PMID: 15573472

DOI: 10.1081/DCT-200039773



Related references

Age effect on perfluorooctanoate (PFOA) plasma concentration in post-weaning rats following oral gavage with ammonium perfluorooctanoate (APFO). Toxicology 225(2-3): 195-203, 2006

The embryo-fetal toxicity and teratogenic potential of ammonium perfluorooctanoate (APFO) in the rat. Fundamental and Applied Toxicology 4(3 Pt 1): 429-440, 1984

Acute and chronic aquatic toxicity of ammonium perfluorooctanoate (APFO) to freshwater organisms. Ecotoxicology and Environmental Safety 71(3): 749-756, 2008

Chronic dietary toxicity and carcinogenicity study with ammonium perfluorooctanoate in Sprague-Dawley rats. Toxicology 298(1-3): 1-13, 2012

The reproductive toxicology of ammonium perfluorooctanoate (APFO) in the rat. Toxicology 196(1-2): 95-116, 2004

Pathology Working Group review and evaluation of proliferative lesions of mammary gland tissues in female rats fed ammonium perfluorooctanoate (APFO) in the diet for 2 years. Drug and Chemical Toxicology 33(2): 131-137, 2010

Absorption, distribution, and excretion of ammonium perfluorooctanoate (APFO) after oral administration to various species. Drug and Chemical Toxicology 29(2): 137-145, 2006

Comparative responses of rats and mice exposed to linear/branched, linear, or branched ammonium perfluorooctanoate (APFO). Toxicology 220(2-3): 203-217, 2006

Cross-sectional study of lipids and liver enzymes related to a serum biomarker of exposure (ammonium perfluorooctanoate or APFO) as part of a general health survey in a cohort of occupationally exposed workers. Journal of Occupational and Environmental Medicine 49(10): 1086-1096, 2007

A 55-week chronic toxicity study of dietary administered kojic acid (KA) in male F344 rats. Journal of Toxicological Sciences 34(3): 305-313, 2009

Male reproductive system parameters in a two-generation reproduction study of ammonium perfluorooctanoate in rats and human relevance. Toxicology 271(1-2): 64-72, 2010

13-week inhalation toxicity study (including 6- and 13-week recovery periods) with ammonium persulfate dust in albino rats. Inhalation Toxicology 13(11): 1033-1045, 2001

Toxicity of ammonium perfluorooctanoate in male cynomolgus monkeys after oral dosing for 6 months. Toxicological Sciences 69(1): 244-257, 2002